alendronate has been researched along with odanacatib in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 13 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Black, WC; Cusick, TE; Duong, LT; Gauthier, JY; Gentile, MA; Kimmel, DB; Masarachia, PJ; Pennypacker, BL; Samadfam, R; Scott, BB; Smith, SY | 1 |
Cabal, A; Cook, L; Dardzinski, BJ; Duong, LT; Evelhoch, JL; Hangartner, TN; Hargreaves, R; Jayakar, RY; Mathers, PD; McCracken, PJ; Motzel, S; Phillips, EA; Posavec, DJ; Sardesai, S; Savitz, AT; Scott, BB; Szumiloski, J; Williams, DS; Winkelmann, CT | 1 |
Brown, K; Cabal, A; Cook, L; Dardzinski, BJ; Duong, LT; Evelhoch, JL; Hangartner, TN; Hargreaves, R; Jayakar, RY; Krause, S; Mathers, PD; McCracken, PJ; Motzel, SL; Pickarski, M; Purcell, M; Savitz, AT; Scott, BB; Somayajula, S; Szumiloski, J; Williams, DS; Winkelmann, CT | 1 |
Bonnick, S; Chapurlat, R; DaSilva, C; De Villiers, T; Gurner, D; Le Bailly De Tilleghem, C; Leung, AT; Odio, A; Palacios, S; Scott, BB | 1 |
Andersen, TL; Delaissé, JM; Duong, LT; Jensen, PR; Pennypacker, BL | 1 |
Kim, H; Kim, M; Ko, H; Yang, W | 1 |
Ikeda, K; Matsuoka, K; Rahman, MM; Takeshita, S | 1 |
Duong, le T; Gatto, NT; Gilberto, D; Kimmel, DB; Pennypacker, BL; Samadfam, R; Smith, SY | 1 |
Bellare, JR; Bora, HK; Chattopadhyay, N; Khan, MP; Nagar, GK; Parameswaran, V; Sanyal, S; Shrivastava, P; Singh, AK; Tiwari, MC | 1 |
Duong, le T; Hu, G; Loboda, A; Muise, ES; Pickarski, M; Podtelezhnikov, AA; Tan, Y; Thomspon, JR | 1 |
Chen, CM; Cusick, T; Duong, LT; Pennypacker, BL; Pickarski, M; Samadfam, R; Scott, K; Smith, SY; Zhuo, Y | 1 |
Consolaro, A; Cunha, NBFF; da Silva, LAB; da Silva, RAB; de Queiroz, AM; Leoni, GB; Nelson-Filho, P; Romualdo, PC; Sousa-Neto, MD | 1 |
Bambery, KR; Buenzli, PR; Duong, LT; Pearson, TA; Pennypacker, BL; Sims, NA; Tobin, MJ; Vrahnas, C | 1 |
1 trial(s) available for alendronate and odanacatib
Article | Year |
---|---|
Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
Topics: Aged; Alendronate; Biomarkers; Biphenyl Compounds; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium, Dietary; Cathepsin K; Cholecalciferol; Combined Modality Therapy; Dietary Supplements; Double-Blind Method; Drug Monitoring; Female; Humans; Medication Adherence; Middle Aged; Osteoporosis, Postmenopausal; Patient Dropouts; Protease Inhibitors | 2013 |
12 other study(ies) available for alendronate and odanacatib
Article | Year |
---|---|
Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits.
Topics: Alendronate; Animals; Biphenyl Compounds; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Cathepsin K; Densitometry; Dose-Response Relationship, Drug; Estradiol; Female; Femur; Haversian System; Rabbits | 2011 |
High-resolution peripheral quantitative computed tomography and finite element analysis of bone strength at the distal radius in ovariectomized adult rhesus monkey demonstrate efficacy of odanacatib and differentiation from alendronate.
Topics: Alendronate; Animals; Biphenyl Compounds; Bone Density; Bone Density Conservation Agents; Finite Element Analysis; Macaca mulatta; Ovariectomy; Radius; Tomography, X-Ray Computed | 2013 |
Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate.
Topics: Alendronate; Animals; Biphenyl Compounds; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Female; Haplorhini; Hip Joint; Ovariectomy; Radiography; Spine | 2013 |
The bone resorption inhibitors odanacatib and alendronate affect post-osteoclastic events differently in ovariectomized rabbits.
Topics: Alendronate; Animals; Biphenyl Compounds; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Female; Osteoclasts; Osteogenesis; Ovariectomy; Rabbits | 2014 |
The effect of cathepsin K inhibitor on osteoclastic activity compared to alendronate and enamel matrix protein.
Topics: Alendronate; Animals; Biphenyl Compounds; Cathepsin K; Cells, Cultured; Dental Enamel Proteins; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mice; Osteoclasts; RANK Ligand; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2015 |
Secretion of PDGF isoforms during osteoclastogenesis and its modulation by anti-osteoclast drugs.
Topics: Alendronate; Animals; Becaplermin; Biphenyl Compounds; Bone Remodeling; Cathepsin K; Cell Differentiation; Cysteine Proteinase Inhibitors; Gene Expression; Lysophospholipids; Mice; Mice, Inbred C57BL; Osteoclasts; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; RNA, Messenger; Sphingosine | 2015 |
Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model.
Topics: Alendronate; Animals; Biphenyl Compounds; Bony Callus; Calcification, Physiologic; Female; Fracture Healing; Osteotomy; Rabbits; Random Allocation; Ulna | 2016 |
Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate.
Topics: Alendronate; Animals; Biomechanical Phenomena; Biphenyl Compounds; Bone Density; Bone Diseases, Metabolic; Calcification, Physiologic; Cancellous Bone; Cortical Bone; Crystallization; Diaphyses; Drugs, Investigational; Estrogens; Female; Femur; Lumbar Vertebrae; Osteoblasts; Osteoclasts; Osteoporosis; Parathyroid Hormone; Rabbits | 2016 |
Effects of Long-Term Odanacatib Treatment on Bone Gene Expression in Ovariectomized Adult Rhesus Monkeys: Differentiation From Alendronate.
Topics: Alendronate; Animals; Biphenyl Compounds; Bone Resorption; Female; Gene Expression Regulation; Macaca mulatta; Osteoclasts; Ovariectomy | 2016 |
Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys.
Topics: Absorptiometry, Photon; Alendronate; Animals; Biomechanical Phenomena; Biphenyl Compounds; Bone and Bones; Bone Density; Bone Remodeling; Cancellous Bone; Cortical Bone; Densitometry; Dose-Response Relationship, Drug; Female; Macaca mulatta; Organ Size; Ovariectomy; Regression Analysis; Tomography, X-Ray Computed | 2016 |
The effect of ovariectomy and 2 antiresorptive therapeutic agents on bone response in rats: A 3-dimensional imaging analysis.
Topics: Alendronate; Animals; Biphenyl Compounds; Bone Density; Female; Femur; Imaging, Three-Dimensional; Maxilla; Ovariectomy; Phenotype; Random Allocation; Rats; Rats, Wistar; X-Ray Microtomography | 2018 |
Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits.
Topics: Alendronate; Animals; Biphenyl Compounds; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Calcification, Physiologic; Female; Osteogenesis; Ovariectomy; Parathyroid Hormone; Rabbits | 2018 |